Sharon Chen is the CEO of AlphaPrime, a global health technology company. Prior to founding AlphaPrime, Sharon was the head of Verily China (Alphabet’s
D-FW biotech firm completes “first ever” AI clinical trial
Sally Ann Frank on LinkedIn: AlphaPrime: Using AI to turbocharge clinical trial processes · TechNode
Antibody Engineering, Antibody Therapeutics
Alice Hsu on LinkedIn: AlphaPrime: Using Al to turbocharge clinical trial processes
Branded Content Archives · TechNode
EISAI PRESENTS FULL RESULTS OF LECANEMAB PHASE 3 CONFIRMATORY CLARITY AD STUDY FOR EARLY ALZHEIMER'S DISEASE AT CLINICAL TRIALS ON ALZHEIMER'S DISEASE (CTAD) CONFERENCE - Nov 29, 2022
TCER® IMA402
TCDI Announces Strategic Partnership with Altumatim to Elevate AI-Powered Document Review and Data Intelligence
Insilico Medicine achieves AI drug discovery breakthrough
TechNode
Undetectable AI Free tool
Sally Ann Frank on LinkedIn: AlphaPrime: Using AI to turbocharge clinical trial processes · TechNode
Anthropic “Claude 3” Models: AI That's Faster, Smarter, and Challenges ChatGPT-4, by AI TutorMaster, Mar, 2024
New Clinical Trial Focuses on Targeted Alpha-Emitter Therapy of PRRT - NETRF